Showing results (1881-1890 of 1,942) with videos related to

Sort By:
Pageof 195
Diabetes Care|December 2, 2025
The Association Between Race/Ethnicity and Risk of Type 2 Diabetes in Women Varies by BMI: A Pooled Analysis of Individual Data From 15 Cohort StudiesKazue Nagai, Hsin-Fang Chung, Kunihiko Hayashi, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitorsJosef R Bencsik, Dengming Xiao, James F Blake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignanciesRobert Z Orlowski, Thomas E Stinchcombe, Beverly S Mitchell, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2014
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognitionWhitney Wharton, Carey E Gleason, N Maritza Dowling, et al.
Physiological Genomics|November 29, 2012
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention StudyVirginia M Miller, Tanya M Petterson, Elysia N Jeavons, et al.
European Journal of Epidemiology|February 21, 2018
Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studiesDongshan Zhu, Hsin-Fang Chung, Nirmala Pandeya, et al.
The Journal of Physiology|December 21, 2020
Silent hypoxaemia in COVID-19 patientsTatum S Simonson, Tracy L Baker, Robert B Banzett, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Delineating regional vulnerability in the neurodegenerative disease SCA1 using a conditional mutant ATXN1 mouseLisa Duvick, W Michael Southern, Kellie Benzow, et al.
Leukemia|June 22, 2016
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignanciesZ A Hing, H Y J Fung, P Ranganathan, et al.
Pageof 195